Insider Transactions Reported by 12 Insiders of Guardian Pharmacy Services, Inc.

Symbol
GRDN on NYSE
Location
Atlanta, GA

Insiders trading volume in the past year

Guardian Pharmacy Services, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas J. Salentine Jr. Director, 10%+ Owner $599,516,899 -$83,872,837 -12% 27 Sep 2025
William E. Bindley Director, 10%+ Owner $598,582,978 -$83,872,837 -12% 27 Sep 2025
Bindley Capital Partners I, LLC 10%+ Owner $210,245,816 -$83,872,837 -29% 27 Sep 2025
John Ackerman Director $184,966,318 -$25,917,273 -12% 27 Sep 2025
Fred Burke President and Chief Executive Officer, Director $129,928,398 -$17,857,869 -12% 11 Feb 2026
Kendall Forbes Executive Vice President, Sales & Operations $66,011,111 -$8,367,388 -11% 01 Mar 2026
David K. Morris Executive Vice President and Chief Financial Officer, Director $55,940,329 -$8,825,221 -14% 01 Mar 2026
Pharmacy Investors, LLC Member of 10% owner group $48,732,198 -$19,440,611 -29% 28 Mar 2025
Cardinal Equity Fund, L.P. Member of 10% owner group $16,235,253 -$6,476,662 -29% 28 Mar 2025
Steven D. Cosler Director $739,776 +$99,786 +16% 03 Dec 2025
Randall J. Lewis Director $252,553 09 May 2025
Mary Sue Patchett Director $252,553 09 May 2025

Recent Insider Transactions by Companies or Individuals for Guardian Pharmacy Services, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Kendall Forbes GRDN Class A Common Stock Award 1.13% 8,952 799,928 01 Mar 2026 Direct
David K. Morris GRDN Class A Common Stock Award 2.07% 8,952 442,327 01 Mar 2026 Direct
Fred Burke GRDN Stock Option (right to buy) Award 75,000 75,000 11 Feb 2026 Direct
Kendall Forbes GRDN Stock Option (right to buy) Award 50,000 50,000 11 Feb 2026 Direct
David K. Morris GRDN Stock Option (right to buy) Award 50,000 50,000 11 Feb 2026 Direct
Fred Burke GRDN Class A Common Stock Gift -11.7% -200,000 1,511,845 04 Dec 2025 Direct
Kendall Forbes GRDN Class A Common Stock Gift -2.65% -21,500 790,976 04 Dec 2025 Direct
Steven D. Cosler GRDN Class A Common Stock Purchase 15.6% $99,786 $29.61 3,370 24,984 03 Dec 2025 Direct
John Ackerman GRDN Class A Common Stock Options Exercise 314.5% 471,057 620,851 27 Sep 2025 By Cardinal Equity Fund, L.P.
John Ackerman GRDN Class A Common Stock Options Exercise 314.5% 1,413,940 1,863,564 27 Sep 2025 By Pharmacy Investors, LLC
John Ackerman GRDN Class B Common Stock Options Exercise -33.3% -471,057 942,114 27 Sep 2025 By Cardinal Equity Fund, L.P.
John Ackerman GRDN Class B Common Stock Options Exercise -33.3% -1,413,940 2,827,878 27 Sep 2025 By Pharmacy Investors, LLC
Kendall Forbes GRDN Class A Common Stock Options Exercise 298.5% 608,570 812,476 27 Sep 2025 Direct
Kendall Forbes GRDN Class B Common Stock Options Exercise -33.3% -608,570 1,217,140 27 Sep 2025 Direct
Cardinal Equity Fund, L.P. GRDN Class A Common Stock Options Exercise 314.5% 471,057 620,851 27 Sep 2025 Direct
Cardinal Equity Fund, L.P. GRDN Class B Common Stock Options Exercise -33.3% -471,057 942,114 27 Sep 2025 Direct
Bindley Capital Partners I, LLC GRDN Class A Common Stock Options Exercise 314.5% 6,100,176 8,039,993 27 Sep 2025 Direct
Bindley Capital Partners I, LLC GRDN Class B Common Stock Options Exercise -33.3% -6,100,176 12,200,350 27 Sep 2025 Direct
Thomas J. Salentine Jr. GRDN Class A Common Stock Options Exercise 314.5% 6,100,176 8,039,993 27 Sep 2025 By Bindley Capital Partners I, LLC
Thomas J. Salentine Jr. GRDN Class B Common Stock Options Exercise -33.3% -6,100,176 12,200,350 27 Sep 2025 By Bindley Capital Partners I, LLC
David K. Morris GRDN Class A Common Stock Options Exercise 299.2% 641,869 856,364 27 Sep 2025 Direct
David K. Morris GRDN Class B Common Stock Options Exercise -33.3% -641,869 1,283,739 27 Sep 2025 Direct
William E. Bindley GRDN Class A Common Stock Options Exercise 314.5% 6,100,176 8,039,993 27 Sep 2025 By Bindley Capital Partners I, LLC
William E. Bindley GRDN Class B Common Stock Options Exercise -33.3% -6,100,176 12,200,350 27 Sep 2025 By Bindley Capital Partners I, LLC
Pharmacy Investors, LLC GRDN Class A Common Stock Options Exercise 314.5% 1,413,940 1,863,564 27 Sep 2025 Direct
Pharmacy Investors, LLC GRDN Class B Common Stock Options Exercise -33.3% -1,413,940 2,827,878 27 Sep 2025 Direct
Fred Burke GRDN Class A Common Stock Options Exercise 314.5% 1,298,826 1,711,845 27 Sep 2025 Direct
Fred Burke GRDN Class B Common Stock Options Exercise -33.3% -1,298,826 2,597,651 27 Sep 2025 Direct
Cardinal Equity Fund, L.P. GRDN Class A Common Stock Sale -25.1% $1,014,149 $20.16 -50,305 149,794 28 May 2025 Direct
Pharmacy Investors, LLC GRDN Class A Common Stock Sale -25.1% $3,044,120 $20.16 -150,998 449,624 28 May 2025 Direct
William E. Bindley GRDN Class A Common Stock Sale -25.1% $13,133,313 $20.16 -651,454 1,939,817 28 May 2025 By Bindley Capital Partners I, LLC
Thomas J. Salentine Jr. GRDN Class A Common Stock Sale -25.1% $13,133,313 $20.16 -651,454 1,939,817 28 May 2025 By Bindley Capital Partners I, LLC
John Ackerman GRDN Class A Common Stock Sale -25.1% $1,014,149 $20.16 -50,305 149,794 28 May 2025 By Cardinal Equity Fund, L.P.
John Ackerman GRDN Class A Common Stock Sale -25.1% $3,044,120 $20.16 -150,998 449,624 28 May 2025 By Pharmacy Investors, LLC
David K. Morris GRDN Class A Common Stock Sale -24.2% $1,381,908 $20.16 -68,547 214,495 28 May 2025 Direct
Fred Burke GRDN Class A Common Stock Sale -25.1% $2,796,293 $20.16 -138,705 413,019 28 May 2025 Direct
Kendall Forbes GRDN Class A Common Stock Sale -24.2% $1,310,219 $20.16 -64,991 203,906 28 May 2025 Direct
Bindley Capital Partners I, LLC GRDN Class A Common Stock Sale -25.1% $13,133,313 $20.16 -651,454 1,939,817 28 May 2025 Direct
Cardinal Equity Fund, L.P. GRDN Class A Common Stock Sale -57.5% $5,462,513 $20.16 -270,958 200,099 27 May 2025 Direct
Pharmacy Investors, LLC GRDN Class A Common Stock Sale -57.5% $16,396,491 $20.16 -813,318 600,622 27 May 2025 Direct
William E. Bindley GRDN Class A Common Stock Sale -57.5% $70,739,525 $20.16 -3,508,905 2,591,271 27 May 2025 By Bindley Capital Partners I, LLC
Thomas J. Salentine Jr. GRDN Class A Common Stock Sale -57.5% $70,739,525 $20.16 -3,508,905 2,591,271 27 May 2025 By Bindley Capital Partners I, LLC
John Ackerman GRDN Class A Common Stock Sale -57.5% $5,462,513 $20.16 -270,958 200,099 27 May 2025 By Cardinal Equity Fund, L.P.
John Ackerman GRDN Class A Common Stock Sale -57.5% $16,396,491 $20.16 -813,318 600,622 27 May 2025 By Pharmacy Investors, LLC
David K. Morris GRDN Class A Common Stock Sale -56.6% $7,443,314 $20.16 -369,212 283,042 27 May 2025 Direct
Fred Burke GRDN Class A Common Stock Sale -57.5% $15,061,576 $20.16 -747,102 551,724 27 May 2025 Direct
Kendall Forbes GRDN Class A Common Stock Sale -56.6% $7,057,169 $20.16 -350,058 268,897 27 May 2025 Direct
Bindley Capital Partners I, LLC GRDN Class A Common Stock Sale -57.5% $70,739,525 $20.16 -3,508,905 2,591,271 27 May 2025 Direct
Steven D. Cosler GRDN Class A Common Stock Award 22% 3,901 21,614 09 May 2025 Direct
Mary Sue Patchett GRDN Class A Common Stock Award 54.6% 3,901 11,043 09 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.